First use in patient of conditionally reprogrammed cells delivers clinical response

Using a newly discovered cell technology, Georgetown University Medical Center researchers were able to identify an effective therapy for a patient with a rare type of lung tumor. The single case study provides a snapshot of the new technology’s promising potential; however, researchers strongly caution that it could be years before validation studies are completed and regulatory approval received for its broader use. Read more here.

Study mentioned: Yuan H, et al. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med. 2012 Sep 27;367(13):1220-7. PMID: 23013073